Maria Licari
Palermo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study).
Journal: European journal of nuclear medicine and molecular imaging
Published: June 03, 2021
Overall survival in mCPRC patients treated with Radium-223 in association with bone health agents: a national multicenter study.
Journal: International journal of radiation biology
Published: October 19, 2020
Validation of the 3-variable prognostic score (3-PS) in mCRPC patients treated with 223Radium-dichloride: a national multicenter study.
Journal: Annals of nuclear medicine
Published: March 30, 2020
Can radium 223 be a conservative non-surgical management of medication-related osteonecrosis of the jaw?
Journal: World journal of nuclear medicine
Published: September 14, 2019
Primary Radical Prostatectomy or Ablative Radiotherapy as Protective Factors for Patients With mCRPC Treated With Radium-223 Dichloride: An Italian Multicenter Study.
Journal: Clinical genitourinary cancer
Published: August 05, 2019
Therapeutic effect of RA223 in the management of breast cancer bone metastases.
Journal: La Clinica terapeutica
Published: February 22, 2019
Hematologic toxicity of radium-223 in elderly patients with metastatic Castration Resistant Prostate Cancer: a real-life experience.
Journal: Prostate international
Published: February 02, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026